Free Trial
OTCMKTS:MRMD

MariMed (MRMD) Stock Price, News & Analysis

MariMed logo
$0.10 0.00 (-0.51%)
As of 08/1/2025 03:51 PM Eastern

About MariMed Stock (OTCMKTS:MRMD)

Key Stats

Today's Range
$0.09
$0.10
50-Day Range
$0.07
$0.12
52-Week Range
$0.07
$0.29
Volume
301,006 shs
Average Volume
361,902 shs
Market Capitalization
$38.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

MariMed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
16th Percentile Overall Score

MRMD MarketRank™: 

MariMed scored higher than 16% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MariMed is -3.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MariMed is -3.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    MariMed has a P/B Ratio of 0.61. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about MariMed's valuation and earnings.
  • Percentage of Shares Shorted

    0.01% of the outstanding shares of MariMed have been sold short.
  • Short Interest Ratio / Days to Cover

    MariMed has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MariMed has recently increased by 1,664.00%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    MariMed does not currently pay a dividend.

  • Dividend Growth

    MariMed does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.01% of the outstanding shares of MariMed have been sold short.
  • Short Interest Ratio / Days to Cover

    MariMed has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MariMed has recently increased by 1,664.00%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    MariMed has a news sentiment score of 0.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.63 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for MariMed this week, compared to 1 article on an average week.
  • MarketBeat Follows

    1 people have added MariMed to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MariMed insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    18.99% of the stock of MariMed is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 0.18% of the stock of MariMed is held by institutions.

  • Read more about MariMed's insider trading history.
Receive MRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MariMed and its competitors with MarketBeat's FREE daily newsletter.

MRMD Stock News Headlines

Market Crash Warning: How to Protect Your Wealth Before August 12th
China tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alternative Assets reveals 3 urgent moves to protect your portfolio, plus the #1 asset class thriving during crises (hint: it’s not stocks or bonds).
See More Headlines

MRMD Stock Analysis - Frequently Asked Questions

MariMed's stock was trading at $0.1158 at the beginning of 2025. Since then, MRMD shares have decreased by 15.8% and is now trading at $0.0975.

MariMed Inc. (OTCMKTS:MRMD) released its earnings results on Wednesday, May, 7th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.01). The company earned $37.96 million during the quarter, compared to the consensus estimate of $38.33 million. MariMed had a negative net margin of 10.33% and a negative trailing twelve-month return on equity of 10.21%.
Read the conference call transcript
.

Shares of MRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MariMed investors own include Canopy Growth (CGC), Innovative Industrial Properties (IIPR), NVIDIA (NVDA), Curaleaf (CURLF), Aurora Cannabis (ACB), Meta Platforms (META) and Tilray Brands (TLRY).

Company Calendar

Last Earnings
5/07/2025
Today
8/02/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:MRMD
Previous Symbol
OTC:MRMD
CIK
1522767
Fax
N/A
Employees
260
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.16 million
Net Margins
-10.33%
Pretax Margin
-4.40%
Return on Equity
-10.21%
Return on Assets
-3.12%

Debt

Debt-to-Equity Ratio
1.21
Current Ratio
1.05
Quick Ratio
0.37

Sales & Book Value

Annual Sales
$157.96 million
Price / Sales
0.24
Cash Flow
$0.02 per share
Price / Cash Flow
4.54
Book Value
$0.16 per share
Price / Book
0.61

Miscellaneous

Outstanding Shares
390,430,000
Free Float
316,291,000
Market Cap
$38.07 million
Optionable
Not Optionable
Beta
3.01
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (OTCMKTS:MRMD) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners